Insulin glulisine

This classification denotes a therapeutic insulin with the molecular formula C258H384N64O78S6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7XIY785AZD, chemically known as insulin (ox), 8a-l-threonine-10a-l-isoleucine-30b-l-threonine- but more generally known as insulin, which bears US NIH Compound Identifier 16129672. European Medicines Agency schedules Insulin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02689MIG. The term INSULIN GLULISINE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 15 No. 3-4, 2001, List 46) WHO schedules insulin in its Anatomical Therapeutic Chemical (ATC) Classification. INSULIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule Insulin glulisine under HS 29371900 and SITC 54154. SMILES:. As of Q4 2014, INSULIN GLULISINE remains US FDA's Preferred Term for this commodity. . Insulin glulisine bears US NLM identifiers UMLS ID C1313386 and NCI Concept Code C65921.